News Release

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 637 2141
US: 215-867-4948

Updated Presentation Time -- Jazz Pharmaceuticals to Present at Credit Suisse Healthcare Conference

November 13, 2007

PALO ALTO, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Robert Myers, the company's President, will provide a corporate presentation at the 2007 Annual Credit Suisse Healthcare Conference in Phoenix, Arizona on November 14, 2007 at 4:30 p.m. Mountain Time (6:30 p.m. Eastern Time). The presentation time has been modified from that which was previously announced.

A live webcast of the presentation may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. A replay will be available on Jazz Pharmaceuticals' website until November 28, 2007.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

For further information see http://www.JazzPharmaceuticals.com.

SOURCE Jazz Pharmaceuticals, Inc.

CONTACT: Jim Karrels, Executive Director, Finance, of Jazz Pharmaceuticals, Inc., +1-650-496-2800, investorinfo@jazzpharmaceuticals.com

Web site: http://www.JazzPharmaceuticals.com